Search results for: 'm ai a medtech'

Frost & Sullivan’s Medtech and Imaging programs explore, articulate, and address the medical industry’s most pressing questions related to growth. The programs focus on core segments such as care delivery, care management, imaging informatics, intelligent imaging, and business models. They independently review and identify companies that are produc...

This study focuses on the top 10 strategic imperatives impacting the MedTech industry in 2025. The industry includes the medical devices and medical imaging and informatics markets. Top transformations impacting industry growth include competitive intensity, compression of the value chain, industry convergence, transformative megatrends, internal...

This Frost & Sullivan study focuses on sustainability in the MedTech industry and offers a detailed discussion on 2 sustainability programs, Climate Action and Responsible Consumption and Production. The study's focus areas include key regulations in the EU, such as the EUDAMED database and green taxonomy and ESG in the United States and Asia-Pacif...

09 Apr 2024  |  North America  |  Market Research

Global Medtech Outlook, 2024

New Product Development and Approvals Drive Industry Growth Opportunities

Infographics

×

The Global MedTech Outlook, 2024 presents a comprehensive analysis of the global MedTech industry in terms of growth potential and important market dynamics. The analysis covers major MedTech segments such as cardiovascular, orthopedics, patient monitoring, respiratory devices, neurology, diabetes care, and clinical-grade wearables. It highlights k...

05 Sep 2024  |  Global  |  Technology Research

R&D Investment Analysis of the Medtech Sector

Artificial Intelligence Integration and Medical Devices Miniaturization to Drive Transformational Growth

Infographics

×

Before the COVID-19 pandemic, medical technology (medtech) registered significant investment in R&D. However, the investment trend declined post-pandemic but is gradually picking up momentum. Top medtech companies invest about 7% to 8% of their total revenues toward the R&D of novel products or to enhance existing products. The key sources for medt...

The healthcare industry has been adapting to changes induced by the COVID-19 pandemic. Medtech, for its part, has been pursuing mergers and acquisitions (M&As) to implement reforms and help the industry recover. Companies in the traditional clinical segments in medtech, such as orthopedics, cardiology, ear, nose, and throat (ENT), wound care, urolo...

The MedTech industry until 2040 encompasses groundbreaking integrations of artificial intelligence (AI), biotechnology, regenerative therapies, nanomedicine, and sustainable digital ecosystems to redefine preventive, personalized, and precision healthcare. These advancements enable real-time genomic editing, implantable biosensors for continuous mo...

About 87% of enterprises believe that artificial intelligence (AI) and machine learning (ML) are important in achieving business goals centered around growing revenue, increasing operational efficiency, and boosting customer experience. However, where are global organizations in this journey and what are their adoption drivers and restraints This F...

AI has moved from being a standalone technology to a core building block that drives global business growth. Advancements in key AI technologies are happening at an exponential pace, constantly unlocking new capabilities and applications. AI adoption is becoming critical for global businesses to stay competitive and relevant. The rising adoption am...